Particle Health Launches Suite of Solutions Built to Wrangle Data for Seven Disease States and Make Actionable Patient Health Information a Reality

Particle FOCUS enables simple and secure access to patient data empowering innovators to support value-based care initiatives, rapidly onboard patients, and optimize care transitions NEW YORK–(BUSINESS WIRE)–#HealthIT—Particle Health, an interoperability platform that aggregates and delivers actionable patient data and insights to healthcare companies, announced it has launched its Particle FOCUS (Filtered Outputs Curated for Usability … [Read more…]

Ally Biotech Announces Acquisition of Popular THC “Chill Pill” Soft Gel Cap Line From Desert Medical Campus, Inc.

“The Chill Pill provides a great delivery system for a consistently accurate dose. We are excited to add new products, expand our team, and bring science and technology to the expansion of business and the brand,” said Ally Biotech VP of Business Development, Francis Baczek. PAYSON, Ariz.–(BUSINESS WIRE)–#Cannabis–Ally Biotech, a science-based company and provider of … [Read more…]

Signature HealthCARE Partners With Real Time Medical Systems to Further Drive Clinical, Operational, and Care Outcomes

Industry’s leading post-acute analytics solution will improve facility-wide outcomes, while aligning with organization’s mission in revolutionizing the healthcare experience for those they serve BALTIMORE, Md.–(BUSINESS WIRE)–Real Time Medical Systems (Real Time), the industry leading, KLAS Rated, and HITRUST Certified post-acute analytics solution today announced its partnership with award-winning Kentucky- based Signature HealthCARE (Signature). Leading the … [Read more…]

MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise

CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher’s additions as advisors expand MMS’ therapeutic area expertise to support growth in different therapeutic areas. … [Read more…]

Southeast Medical Group with Local, Growing Georgia Health Plan

Addition of state’s fastest growing primary care partnership reflects Sonder Health Plans’ commitment to member choice and value ATLANTA–(BUSINESS WIRE)–Sonder Health Plans, a local Georgia health plan providing personalized and affordable Medicare Advantage programs to residents, announce today the addition of Southeast Medical Group to its provider network. As the state’s largest partnership of independent … [Read more…]

Caldera Medical Chosen by Real Leaders® as No. 7 for Healthcare Companies and No. 162 out of 300 Worldwide “Top Impact Companies in 2023”

LOS ANGELES–(BUSINESS WIRE)–#calderamedical–Caldera Medical, a women’s health medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced that Real Leaders® has chosen the company as No. 7 in Healthcare and No. 162 out of 300 “Top Impact Companies in 2023” from around the globe. … [Read more…]

UR Medicine Chooses DexCare to Power On-Demand Virtual Visits

New offering expands care access to serve more patients across New York through UR Medicine’s Get Care Now program; sees strongly positive responses from early users SEATTLE–(BUSINESS WIRE)–DexCare, Inc., the leading data-driven intelligence company focused on creating exceptional healthcare access experiences for everyone, today announced an agreement with UR Medicine, the clinical enterprise of the … [Read more…]

Axalbion to Present Promising Phase 2 Clinical Data in Chronic Cough with AX-8, a Novel TRPM8 Agonist, in an Oral Presentation at the American Thoracic Society (ATS) 2023 International Conference

Proof-of-Concept Study Signals AX-8’s Potential in Chronic Cough Treatment, Especially in Patients with Moderate-to-Severe Throat Discomfort MANCHESTER, England & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–#TRPM8agonist–Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, announced that it will present positive results from a Phase 2 proof-of-concept study with its transient receptor potential melastatin 8 … [Read more…]

Lumicell Submits New Drug Application for LUMISIGHT™ Optical Imaging Agent to U.S. FDA for Intraoperative Breast Cancer Detection and Removal

Novel optical imaging agent highlights cancerous tissue during initial lumpectomy to enable a more complete resection as part of the investigational Lumicell Direct Visualization System LUMISIGHT was previously granted Fast Track designation by the FDA Pan-oncological optical imaging agent also being studied for other solid tumors NEWTON, Mass.–(BUSINESS WIRE)–#BreakthroughDevice—Lumicell, Inc., a privately held company focused … [Read more…]